General Information of DTT (ID: TT15SL0)

DTT Name Proheparin-binding EGF-like growth factor (HBEGF) DTT Info
Gene Name HBEGF

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Clinical Trial Drug(s)
3 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
ASP0598 DM9QUCH Chronic tympanic membrane perforation AB13 Phase 1 [1]
KHK-2866 DMR7EF6 Ovarian cancer 2C73 Phase 1 [2]
U3-1565 DMWOE62 Solid tumour/cancer 2A00-2F9Z Phase 1 [3]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 ClinicalTrials.gov (NCT04305184) A Phase 1/2, Randomized, Placebo-controlled Study to Assess the Safety, Tolerability, Efficacy, and Pharmacokinetics of ASP0598 Otic Solution Following Topical Application Into the Ear in Subjects With Chronic Tympanic Membrane Perforation (CTMP). U.S.National Institutes of Health.
2 ClinicalTrials.gov (NCT01279291) Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer. U.S. National Institutes of Health.
3 J Clin Oncol 31, 2013 (suppl; abstr 2519).